The European Union drug regulator has announced that the data available support the safety and efficacy of the third booster dose of Covid-19 vaccine three months after the second dose.
Although the current recommendation is for booster doses to be given after six months, the data available today support the safety and efficacy of boosting the third booster dose of Covid-19 three months later. from the second installment, said Marco Cavaleri, head of the European Medicines Agency (EMA) Vaccine Strategy, during a press conference.
Referring to the vaccination campaign for children aged 5 to 11, he said that so far no safety issues have been reported.
Regarding the variant, Omicron stated that so far the majority of cases in the European Union are a mild manifestation of the disease.
“Most of the cases are mild, but we need to gather more data to determine if the range of severity of the disease caused by Omicron is different from the range of other variants that have been released to date,” added Marco Cavaleri.
Follow Skai.gr on Google News
and be the first to know all the news
.
